Target intelligence / Profile preview

ATP synthase F(1) complex catalytic subunit beta, mitochondrial (ATP5F1B)

Target
ATP5F1B
Molecular classification
Enzyme, Transporter
01

Overview

The mitochondrial ATP synthase F1 subunit beta (ATP5F1B) is a critical component of the F1 sector of the F1Fo-ATP synthase complex, also known as Complex V of the mitochondrial respiratory chain (UniProt). This subunit contains the catalytic site responsible for the synthesis of ATP from ADP and inorganic phosphate, driven by the proton motive force across the inner mitochondrial membrane (Wikipedia). Beyond its central role in bioenergetics, ATP5F1B is found ectopically on the plasma membrane of certain cells, where it acts as a receptor for various ligands, including angiostatin and high-density lipoproteins (PubMed). In cancer, the overexpression or cell-surface translocation of this subunit is associated with increased metastasis and poor prognosis, making it an attractive target for anti-angiogenic and anti-tumor therapies (NIH). Mutations in the ATP5F1B gene are linked to mitochondrial diseases such as complex V deficiency and neurodegenerative conditions like dystonia (PubMed). Pharmacological modulation of the beta subunit by inhibitors like aurovertin B or dietary polyphenols can disrupt cellular energy metabolism, though systemic inhibition poses significant safety risks due to the enzyme's essential role in all aerobic cells (NIH).

Other names
ATP synthase subunit beta, mitochondrialATP synthase F1 complex subunit betaATP5BATPMBATPSBF1-ATPase beta subunit
02

Mechanism of action

Inhibition of the catalytic activity of the F1 sector by binding to the beta subunit or the alpha/beta interface, thereby blocking the rotational mechanism or the binding of ADP/ATP, which halts ATP synthesis and hydrolysis.

03

Biological functions

ApoptosisCell deathEnergy metabolismProton transportOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMitochondrial diseaseOther
05

Safety considerations

Systemic toxicity due to inhibition of essential energy productionMitochondrial dysfunctionOxidative stressApoptosis in healthy tissues
06

Interacting drugs

Aurovertin B

8 more in the full profile.

07

Biomarkers

ATP5B mRNA expressionEctopic ATP5B protein levelsMitochondrial membrane potential

Beyond the preview

Go deeper on ATP synthase F(1) complex catalytic subunit beta, mitochondrial (ATP5F1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase F(1) complex catalytic subunit beta, mitochondrial (ATP5F1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call